Skip to main content

Table 1 Characteristics of study participants

From: Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma

 

TNET

N = 9

TC

N = 16

P-value

Sex

   

Male

Female

8(32)

1(4)

8(32)

8(32)

0.051

Age, years

   

Mean/ Range

60.0 / 45–83

61.6 / 39–82

0.737

Histology

LCNEC 3 (33)

Ac 2 (22)

SCC 2(22)

*Other 2(22)

Sq 15 (93)

AdSq 1 (7)

-

Tumor size. mm

   

Mean/ Range

61.8 / 34–104

53 / 20–100

0.527

Masaoka stage

   

I

II

III

IV

0(0)

3(33)

3(33)

3(33)

1 (6)

4 (25)

7 (43)

4 (25)

0.800

Preoperative therapy

   

No

Yes

7(77)

2(22)

14(87)

2 (12)

0.527

Combined resection

   

Yes

No

6(66)

3(33)

13(81)

3(18)

0.412

Lymph node metastases

   

N0

N1, 2

8 (88)

1(11)

13 (81)

3(18)

0.617

Resection status

   

R0

R1,2

8 (88)

1(11)

13(81)

3(18)

0.617

Postoperative therapy

   

No

Yes

5 (55)

4(44)

5(31)

11 (68)

0.233

Recurrence

   

No

Yes

4 (44)

5 (55)

11 (68)

5 (31)

0.233

  1. * “Other” includes: Thymic carcinoma with neuroendocrine carcinoma components (1), poorly differentiated thymic neuroendocrine carcinoma (1)
  2. TNET, thymic neuroendocrine tumors; TC, thymic carcinoma; LCNEC, large cell neuroendocrine carcinoma; Ac, atypical carcinoid; SCC, small cell carcinoma; Sq, squamous cell carcinoma; AdSq, adenosquamous carcinoma